Correvio Pharma Corp. postpones announcement of financial statements for the first quarter ended March 31, 2020. The company announced that it has postponed the reporting of its financial statements and management discussion and analysis in respect of the first quarter ended March 31, 2020 beyond the previous expected date of May 15, 2020. The company now expects to release its 2020 Disclosure on or before June 29, 2020, subject to the Company ceasing to be a reporting issuer prior to the filing deadline as a result of the Proposed Arrangement.